Document Detail


Current treatment of venous thromboembolism.
MedLine Citation:
PMID:  20139364     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Venous thromboembolism, comprising deep vein thrombosis and pulmonary embolism, is a common disorder with at least 250 000 new events occurring each year in the United States alone. Treatment of venous thromboembolism includes anticoagulation, which is achieved initially with the use of a parenterally administered agent followed by a more prolonged course of treatment with an oral vitamin K antagonist. The duration of treatment depends on the clinical assessment of the benefit-to-risk ratio of prolonged anticoagulation versus the risk of recurrent events. In this review, we discuss some of the issues that we believe are among the most critical unanswered questions in the management of venous thromboembolism in the present era.
Authors:
Nigel S Key; Raj S Kasthuri
Related Documents :
3341094 - Systemic complication of intracavernous papaverine injection in patients with venous le...
3656534 - Spongiosolysis: a new surgical treatment of impotence caused by distal venous leakage.
6864304 - Possible significance of juvenile oral venous angioma as marker of intracerebral vascul...
1729744 - Arterial emboli of venous origin.
688584 - The genesis of the diastolic murmur of complete heart block. phono-echocardiographic ob...
23438544 - Intrapericardial extralobar pulmonary sequestration in adult.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review     Date:  2010-02-05
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  30     ISSN:  1524-4636     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-02-19     Completed Date:  2010-04-01     Revised Date:  2014-09-19    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  372-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use*
Humans
Postthrombotic Syndrome / prevention & control
Recurrence / prevention & control
Venous Thrombosis / drug therapy*
Vitamin K / antagonists & inhibitors
Grant Support
ID/Acronym/Agency:
R01 HL095096/HL/NHLBI NIH HHS; R01 HL095096/HL/NHLBI NIH HHS; R01 HL095096-01/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Anticoagulants; 12001-79-5/Vitamin K
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of Factor XIa as a New Approach to Anticoagulation.
Next Document:  D609 Inhibits Progression of Preexisting Atheroma and Promotes Lesion Stability in Apolipoprotein E-...